XKLS
IHH
Mar 24, Last price
6.54MYR
Name
IHH Healthcare Bhd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IHH Healthcare Berhad, established in 2010 and headquartered in Kuala Lumpur, Malaysia, operates as an investment holding conglomerate delivering an extensive spectrum of healthcare services. Its operational footprint spans across Malaysia, Singapore, Turkey, India, China, Japan, Europe, and other international markets. The company provides a full continuum of medical care, beginning with fundamental primary services like treatment for common illnesses, outpatient consultations, health screenings, immunizations, and preventive health education. This progresses to intermediate secondary care, featuring specialist consultations, minor surgical procedures, emergency interventions, comprehensive laboratory and diagnostic services, and acute medical treatment. More advanced tertiary care encompasses highly specialized consultations, cutting-edge therapies, intricate surgical operations, and extensive inpatient management. The most complex quaternary care includes critical procedures such as organ transplantation, neurosurgery, advanced cardiac surgery, and reconstructive plastic surgery. Beyond direct patient care, IHH Healthcare offers vital support services including advanced diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, integrated rehabilitation, and molecular diagnostics. The group also engages in medical education programs for nurses, physicians, and allied healthcare professionals, alongside administrative, management, and advisory services. Its specialized care offerings extend to emergency, home-based, orthopedic, and ambulatory services. Further diversifying its portfolio, the company provides healthcare information systems, web-based applications, and various technological solutions. It also handles services related to real estate investment trusts, manages dialysis and treasury centers, and operates a network of educational institutions, colleges, and research-focused learning centers. Its infrastructure arm is responsible for the development, construction, oversight, management, and leasing of medical and healthcare facilities. Complementary services include catering, laundry, and cleaning for hospitals, as well as the import and wholesale of pharmaceutical and medical supplies. Additionally, IHH Healthcare is involved in property leasing and provides software system integration and application management services.
Key people
Non-Independent Non-Executive Chairman of the Board · since 2018
Chief Executive Officer, Managing Director, Non-Independent Executive Director · since 2014
Group Chief Financial Officer · since 2016
Aziz Baba Abdul
President - IMU Health Sdn Bhd, Chief Executive Officer, Vice-Chancellor - IMU Education Sdn Bhd · since 2018
Group Head, Strategic Planning & Business Development, (Merger & Acquisition), Chief Executive Officer - South East Asia Operations Division · since 2018
Tahsin Guney
Chief Executive Officer - Acibadem Saglik Yatirimlari Holding A.S · since 2019
Suet Wun Lim
Group Chief Operating Officer · since 2018
Fay Lin Teo
Group Chief Human Resource Officer · since 2017
Executive Director · since 2019
Nili Shayrina Binti Saat
Head - Risk Management · since 2018
lok Sen Huang
Group Head - Internal Audit · since 2013
Ida Suryati Binti Ab Rahim
Joint Secretary · since 2019
Beng Sze Lim
Group Head, Legal and Company Secretary · since 2014
Mehmet Ali Aydinlar
Non-Independent Non-Executive Director · since 2019
Takeshi Saito
Non-Independent Non-Executive Director · since 2019
Kaichi Yokoyama
Non-Independent Non-Executive Director · since 2012
Independent Non-Executive Director · since 2014
Pei Lynn Quek
Non-Independent, Non-Executive Director · since 2016
Independent Non-Executive Director · since 2018
Valuation
Title MYR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||